These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 37012)

  • 1. Nadolol eye drops in glaucoma and ocular hypertension: a controlled clinical study of dose response and duration of action.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):309-14. PubMed ID: 6119925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nadolol and labetalol: comparative efficacy of two beta-blocking agents in glaucoma.
    Krieglstein GK; Kontić D
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):313-7. PubMed ID: 6114677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug.
    Frishman W
    Am Heart J; 1980 Jan; 99(1):124-8. PubMed ID: 6101295
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
    Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J
    Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.